Correlation Between Tempest Therapeutics and Kaleido Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Kaleido Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Kaleido Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Kaleido Biosciences, you can compare the effects of market volatilities on Tempest Therapeutics and Kaleido Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Kaleido Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Kaleido Biosciences.

Diversification Opportunities for Tempest Therapeutics and Kaleido Biosciences

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Tempest and Kaleido is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Kaleido Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kaleido Biosciences and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Kaleido Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kaleido Biosciences has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Kaleido Biosciences go up and down completely randomly.

Pair Corralation between Tempest Therapeutics and Kaleido Biosciences

If you would invest  86.00  in Tempest Therapeutics on November 2, 2024 and sell it today you would earn a total of  9.00  from holding Tempest Therapeutics or generate 10.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy5.26%
ValuesDaily Returns

Tempest Therapeutics  vs.  Kaleido Biosciences

 Performance 
       Timeline  
Tempest Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Tempest Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Tempest Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Kaleido Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kaleido Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Kaleido Biosciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Tempest Therapeutics and Kaleido Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tempest Therapeutics and Kaleido Biosciences

The main advantage of trading using opposite Tempest Therapeutics and Kaleido Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Kaleido Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kaleido Biosciences will offset losses from the drop in Kaleido Biosciences' long position.
The idea behind Tempest Therapeutics and Kaleido Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance